PRIMARY STUDY

The neuroprotection of cannabidiol against MPP(+)-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease.

Key Findings:  This is the first study to report the involvement of neuronal proteins and nerve growth factor (NGF) receptors (trkA) in the neuroprotection of CBD. Findings suggest that CBD has a neurorestorative potential independent of NGF that might contribute to its neuroprotection against 1-methyl-4-phenylpyridinium iodide [MPP(+)], a neurotoxin relevant to Parkinson's disease.

Type of Study:  Laboratory Study

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable


Study Location(s):  Brazil

Year of Pub:  2015


Link to study